Table 3.
Multivariate logistic regression analysis of lipid profile levels and the risk of hypertension.
Crude Model | Model 1 | Model 2 | Model 3 | |||||
---|---|---|---|---|---|---|---|---|
TG | OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value | OR (95% CI) | P-value |
Q 1 (≤68.22 mg/dl) | Ref | Ref | Ref | Ref | ||||
Q 2 (68.22-97.46 mg/dl) | 0.94 (0.869-1.018) | 0.127 | 0.984 (0.902-1.072) | 0.707 | 0.975 (0.893-1.065) | 0.577 | 1.023 (0.892-1.173) | 0.745 |
Q 3 (97.46-146.19 mg/dl) | 1.03 (0.956-1.112) | 0.434 | 0.999 (0.919-1.085) | 0.976 | 1.001 (0.920-1.09) | 0.979 | 1.036 (0.907-1.183) | 0.603 |
Q 4 (≥146.19 mg/dl) | 0.999 (0.925-1.079) | 0.975 | 0.978 (0.899-1.065) | 0.612 | 0.987 (0.906-1.076) | 0.770 | 1.038 (0.906-1.188) | 0.593 |
Per 1 mg/dl increase | 1.000 (1.000-1.001) | 0.062 | 1.000 (1.000-1.000) | 0.315 | 1.000 (1.000-1.001) | 0.238 | 1.000 (1.000-1.001) | 0.189 |
p for trend | 0.487 | 0.712 | 0.926 | 0.569 | ||||
TC | ||||||||
Q 1 (≤158.89 mg/dl) | Ref | Ref | Ref | Ref | ||||
Q 2 (158.89-180.54 mg/dl) | 1.562 (1.411-1.739) | <0.001 | 1.141 (1.024-1.27) | 0.017 | 1.111 (0.996-1.240) | 0.059 | 1.03 (0.87-1.211) | 0.752 |
Q 3 (180.54-204.90 mg/dl) | 2.556 (2.326-2.809) | <0.001 | 1.337 (1.207-1.48) | <0.001 | 1.269 (1.144-1.407) | <0.001 | 1.164 (0.997-1.36) | 0.054 |
Q 4 (≥204.90 mg/dl) | 4.548 (4.158-4.974) | <0.001 | 1.402 (1.269-1.55) | <0.001 | 1.322 (1.195-1.463) | <0.001 | 1.176 (1.009-1.371) | 0.038 |
Per 1 mg/dl increase | 1.015 (1.014-1.016) | <0.001 | 1.003 (1.002-1.004) | <0.001 | 1.003 (1.002-1.003) | <0.001 | 1.002 (1.000-1.003) | 0.008 |
p for trend | <0.001 | <0.001 | <0.001 | 0.013 | ||||
LDL-c | ||||||||
Q 1 (≤86.99 mg/dl) | Ref | Ref | Ref | Ref | ||||
Q 2 (86.99-102.84 mg/dl) | 1.55 (1.406-1.709) | <0.001 | 1.161 (1.046-1.289) | 0.005 | 1.106 (0.994-1.230) | 0.064 | 1.015 (0.862-1.195) | 0.859 |
Q 3 (102.84-121.01 mg/dl) | 2.413 (2.202-2.645) | <0.001 | 1.338 (1.212-1.478) | <0.001 | 1.247 (1.127-1.380) | <0.001 | 1.188 (1.018-1.387) | 0.029 |
Q 4 (≥121.01 mg/dl) | 3.969 (3.638-4.330) | <0.001 | 1.371 (1.245-1.511) | <0.001 | 1.265 (1.147-1.396) | <0.001 | 1.170 (1.005-1.362) | 0.044 |
Per 1 mg/dl increase | 1.017 (1.016-1.018) | <0.001 | 1.003 (1.002-1.004) | <0.001 | 1.003 (1.002-1.004) | <0.001 | 1.002 (1.000-1.004) | 0.017 |
p for trend | <0.001 | <0.001 | <0.001 | 0.011 | ||||
HDL-c | ||||||||
Q 1 (≤48.71 mg/dl) | Ref | Ref | Ref | Ref | ||||
Q 2 (48.71-56.06 mg/dl) | 0.808 (0.75-0.870) | <0.001 | 0.848 (0.782-0.920) | <0.001 | 0.927 (0.854-1.007) | 0.074 | 0.993 (0.871-1.132) | 0.919 |
Q 3 (56.06-63.79 mg/dl) | 0.813 (0.754-0.877) | <0.001 | 0.797 (0.733-0.867) | <0.001 | 0.934 (0.857-1.017) | 0.117 | 1.078 (0.944-1.231) | 0.267 |
Q 4 (≥63.79 mg/dl) | 0.694 (0.642-0.750) | <0.001 | 0.643 (0.590-0.701) | <0.001 | 0.871 (0.797-0.952) | 0.002 | 0.894 (0.772-1.036) | 0.137 |
Per 1 mg/dl increase | 0.988 (0.986-0.991) | <0.001 | 0.986 (0.983-0.988) | <0.001 | 0.995 (0.993-0.998) | 0.001 | 0.996 (0.991-1.000) | 0.063 |
p for trend | <0.001 | <0.001 | 0.004 | 0.407 | ||||
non-HDL-c | ||||||||
Q 1 (≤103.61 mg/dl) | Ref | Ref | Ref | Ref | ||||
Q 2 (103.61-122.94 mg/dl) | 1.748 (1.573-1.943) | <0.001 | 1.224 (1.113-1.391) | <0.001 | 1.128 (1.007-1.264) | 0.038 | 0.883 (0.742-1.051) | 0.161 |
Q 3 (122.94-146.52 mg/dl) | 2.934 (2.658-3.239) | <0.001 | 1.486 (1.337-1.653) | <0.001 | 1.293 (1.161-1.440) | <0.001 | 1.189 (1.011-1.398) | 0.036 |
Q 4 (≥146.52 mg/dl) | 5.624 (5.124-6.173) | <0.001 | 1.694 (1.528-1.878) | <0.001 | 1.382 (1.244-1.535) | <0.001 | 1.116 (0.950-1.311) | 0.181 |
Per 1 mg/dl increase | 1.017 (1.017-1.018) | <0.001 | 1.005 (1.004-1.006) | <0.001 | 1.003 (1.002-1.004) | <0.001 | 1.002 (1.001-1.004) | 0.003 |
p for trend | <0.001 | <0.001 | <0.001 | 0.008 |
OR, odds ratio; CI, confidence interval; Q, quartile; Model 1 adjust age; Model 2 adjust age and BMI. Model 3 adjust Model 2+ FPG (mmol/L), ALT, AST, BUN, Scr, smoking status (current smoker or not), drinking status (current drinker or not), family history of diabetes (Yes or No).